Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability

Neurogenetics

Volumn 16, Issue 3, 2015, Pages 161-168

  Akkad, Denis A ^a   Bellenberg, Barbara ^b   Esser, Sarika ^a   Weiler, Florian ^c   Epplen, Jörg T ^a   Gold, Ralf ^b   Lukas, Carsten ^b   Haghikia, Aiden ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c FRAUNHOFER MEVIS   (Germany)

Author keywords

Cervical cord atrophy; Genome wide association study; MRI; Multiple sclerosis; Paraclinical phenotype; Risk genes

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CERVICAL SPINAL CORD; CLINICAL EXAMINATION; COHORT ANALYSIS; DISABILITY; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HISTOCOMPATIBILITY COMPLEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SPINAL CORD ATROPHY; VOLUMETRY; ATROPHY; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATROPHY; CERVICAL CORD; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84931562423     PISSN: 13646745     EISSN: 13646753     Source Type: Journal    
DOI: 10.1007/s10048-015-0438-0     Document Type: Article

References (19)

1. Oksenberg JR, Baranzini SE (2010) Multiple sclerosis genetics–is the glass half full, or half empty? Nat Rev Neurol 6:429–437
2. Sawcer S et al (2010) What role for genetics in the prediction of multiple sclerosis? Ann Neurol 67:3–10
3. Gregory AP et al (2012) TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488:508–511
4. van Oosten BW et al (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47:1531–1534
5. Liguori M et al (2011) HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study. Genes Immun 12:183–190
6. Imrell K et al (2006) Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67:1062–1064
7. Healy BC et al (2010) HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology 75:634–640
8. Lill CM et al (2012) Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29,000 subjects. J Med Genet 49:558–562
9. Sawcer S et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214–219
10. McDonald WI et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121–127
11. Roxburgh RH et al (2005) Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 64:1144–1151
12. Lukas C et al (2013) Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology 269:542–552
13. De Jager PL et al (2009) Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 8:1111–1119
14. Rocca MA et al (2011) A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology 76:2096–2102
15. Shahijanian F et al (2014) The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells. Hum Mol Genet 23:1425–1434
16. Mowry EM et al (2013) Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. PLoS One 8:e75416
17. Gourraud PA et al (2011) Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol 69:65–74
18. Evangelou N et al (2005) Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain: J Neurology 128:29–34
19. Lukas C. et al (2014) Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry